Bausch & Lomb Incorporated clinical trials

Acquired by Bausch Health Companies Inc., Aug 5, 2013 · source ↗

The registry lists 225 studies whose lead sponsor is Bausch & Lomb Incorporated. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 225. List all 225 → · All Bausch Health Companies Inc. studies →

• BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution TrialNot yet recruitingNCT07778888Phase 2

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic AstigmatismNot yet recruitingNCT07377474Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• IC-8 Apthera IOL New Enrollment Post Approval StudyRecruitingNCT06060041

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2RecruitingNCT06997003Not applicable

  Sponsor listed in the registry: Bausch & Lomb GmbH · First submitted after Bausch & Lomb GmbH became part of Bausch Health Companies Inc.

• A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in ChildrenRecruitingNCT06305663Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive KeratectomyNot yet recruitingNCT06618547Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive KeratectomyCompletedNCT07412496Phase 2

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Revive Toric RWE StudyWithdrawnNCT06785194

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without AstigmatismCompletedNCT05264623Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• 1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for AstigmatismCompletedNCT05320042Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial ParticipantsCompletedNCT07717918Phase 1

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• 1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact LensesCompletedNCT06053736Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact LensesCompletedNCT05129488Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• 1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Multifocal Compared to Ultra for PresbyopiaCompletedNCT05325931Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Surface Refractive Index Shift of Kalifilcon A Compared With Dailies Total1 and Precision1 LensesCompletedNCT04840563Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT07168902Phase 2

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye DiseaseCompletedNCT07128628Phase 2

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06333015Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive AccuracyCompletedNCT06346340Phase 4

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06594185Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular RednessCompletedNCT06803654Phase 3

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) LensTerminatedNCT06479148Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Post-Market Clinical Follow-Up on Safety and Performance of the Ophthalmic Viscoelastic Devices Eyefill SC and Eyefill MBCompletedNCT06767917Not applicable

  Sponsor listed in the registry: Bausch & Lomb GmbH · First submitted after Bausch & Lomb GmbH became part of Bausch Health Companies Inc.

• A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy VolunteersActive, not recruitingNCT06978244Phase 1

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Evaluate Concomitant Perfluorohexyloctane Use With Contact Lens WearCompletedNCT07054606Phase 4

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye DiseaseWithdrawnNCT07111013Phase 3

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye DiseaseCompletedNCT06309953Phase 4

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology LensCompletedNCT05984290Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• 2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra LensesCompletedNCT05126953Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic SolutionCompletedNCT05815758Phase 3

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact LensesCompletedNCT05129124Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Effects of NOV03 on the Tear FilmCompletedNCT05723770Phase 4

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic ConjunctivitisCompletedNCT05591755Phase 3

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Orientation Characteristics of Daily Disposable Toric Contact LensesCompletedNCT06069609Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric LensesCompletedNCT05129072Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Evaluate the Safety and Effectiveness of a Contact Lens Cleaning and Disinfecting SolutionCompletedNCT05565937Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06333028

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Safety and IOP-Lowering Effects of WB007CompletedNCT04149899Phase 1/2

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic ConjunctivitisCompletedNCT05579730Phase 3

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular LensCompletedNCT03603600Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.Active, not recruitingNCT06565650Phase 4

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Kalifilcon A Toric Compared to Commercially Available LensesCompletedNCT06098937Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)CompletedNCT04139798Phase 3

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Clinical Study to Evaluate the Safety and Performance of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT04224155Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Evaluation of Ocular Comfort With ISTA Tears vs SystaneCompletedNCT01650584Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted before Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• "Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness"CompletedNCT05360784Phase 3

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)CompletedNCT04567329Phase 3

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Safety and Effectiveness Study of a New Preservative Free Rewetting DropCompletedNCT04175340Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study With Technolas® TENEO 317 Model 2 Excimer Laser to Treat Participants With Myopia or Myopic AstigmatismCompletedNCT04111757Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50CompletedNCT04192630Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.